Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

for
Ulcerative Colitis
Location: Houston TX, St Louis MO, Marietta GA, Tampa FL,
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06975722

Phase2, Recruiting

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

for
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma,
Location: Houston TX, Nashville TN, Tampa FL, Ann Arbor MI,
Sponsor: Remix Therapeutics

Sex: All

Age: 18+

Code: NCT06118086

Phase1, Phase2, Recruiting

Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens

for
Postoperative Visual Outcomes Following Cataract Surgery in Patients With Prior Myopic Corneal Laser Vision Correction,
Location: Sugar Land TX, Lynchburg VA
Sponsor: Carl Zeiss Meditec AG

Sex: All

Age: 18+

Code: NCT07084545

Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Houston TX, Round Rock TX, Temple TX, San Antonio TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

North American Fetal Therapy Network for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia

for
Congenital Diaphragmatic Hernia
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: Female

Age: 18+

Code: NCT06739356

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

for
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS),
Location: Houston TX, Dallas TX, Denver CO, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06465953

Phase3, Recruiting

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

for
Peripheral Neuropathies,
Location: Galveston TX, Pittsburgh PA, Amherst NY
Sponsor: RxFunction Inc.

Sex: All

Age: 55+

Code: NCT06959277

Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

for
Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer),
Location: Houston TX, Irving TX, Denver CO, Jacksonville FL,
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05873686

Phase1, Recruiting

Application of Virtual Reality Technology to Treatment of Social Anxiety

for
Autism Spectrum Disorder, Social Anxiety Disorder
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT06845488

Recruiting

5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06887218

Phase2, Recruiting

Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06769490

Phase1, Recruiting

An Observational Study of Individuals With Isolated Dystonia

for
Isolated/Primary Dystonia That Affects More Than One Region of the Body,
Location: Houston TX, Dallas TX, Charleston SC, Chicago IL,
Sponsor: Vima Therapeutics

Sex: All

Age: 12 - 65

Code: NCT07111663

Recruiting

New Assessment System in Measuring Symptom Distress in Cancer Patients

for
Caregiver, Health Care Provider, Malignant Neoplasm, Physician
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00505245

Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for
Familial Adenomatous Polyposis (FAP)
Location: Houston TX, Kansas City KS, St Louis MO, Orlando FL,
Sponsor: Rapamycin Holdings Inc.

Sex: All

Age: 18+

Code: NCT06950385

Phase3, Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

for
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma,
Location: Houston TX, Aurora CO, Chicago IL, Scottsdale AZ,
Sponsor: SciTech Development, Inc.

Sex: All

Age: 18+

Code: NCT04234048

Phase1, Recruiting

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

for
Type 1 Diabetes Mellitus, T1D, T1DM,
Location: Humble TX, Austin TX, San Antonio TX, Waxahachie TX,
Sponsor: COUR Pharmaceutical Development Company, Inc.

Sex: All

Age: 12 - 35

Code: NCT06783309

Phase1, Phase2, Recruiting

AERA Pediatrics Registry

for
Dysfunction of Eustachian Tube
Location: Houston TX, Fort Worth TX, Cincinnati OH,
Sponsor: Integra LifeSciences Corporation

Sex: All

Age: 0 - 18

Code: NCT07071298

Recruiting

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

for
Hormone-receptor-positive Breast Cancer,
Location: Houston TX, Iowa City IA, Seattle WA
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06756932

Phase1, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant
Location: Houston TX, Dallas TX, Nashville TN, Tampa FL, Omaha NE,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase3, Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

for
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,
Location: Houston TX, Lexington KY, Chicago IL, Madison WI,
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05691465

Phase2, Recruiting